Fumagillin‐induced aseptic meningoencephalitis in a kidney transplant recipient with microsporidiosis | Zendy

Audemard A. | Zendy; Le Bellec M.L. | Zendy; Carluer L. | Zendy; Dargère S. | Zendy; Verdon R. | Zendy; Castrale C. | Zendy; Lobbedez T. | Zendy; Hurault de Ligny B. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Fumagillin‐induced aseptic meningoencephalitis in a kidney transplant recipient with microsporidiosis

Author(s) -

Audemard A.,

Le Bellec M.L.,

Carluer L.,

Dargère S.,

Verdon R.,

Castrale C.,

Lobbedez T.,

Hurault de Ligny B.

Publication year - 2012

Publication title -

transplant infectious disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.69

H-Index - 67

eISSN - 1399-3062

pISSN - 1398-2273

DOI - 10.1111/tid.12010

Subject(s) - microsporidiosis , fumagillin , medicine , meningoencephalitis , immunosuppression , opportunistic infection , microsporidia , enterocytozoon bieneusi , immunology , virology , human immunodeficiency virus (hiv) , viral disease , biology , microbiology and biotechnology , angiogenesis , protozoal disease , malaria , spore

Microsporidiosis is an opportunistic infection in organ transplant recipients and patients with other cellular immunodeficiency. Fumagillin is an effective treatment against E nterocytozoon bieneusi , one of the two main species causing the microsporidiosis involved in human diseases. We report the first case, to our knowledge, of a probable drug‐induced aseptic meningoencephalitis, after administration of fumagillin in a kidney transplant recipient with microsporidiosis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research